vs
CNO Financial Group, Inc.(CNO)与伊萨(ESAB)财务数据对比。点击上方公司名可切换其他公司
CNO Financial Group, Inc.的季度营收约是伊萨的1.6倍($1.1B vs $727.8M),CNO Financial Group, Inc.净利率更高(8.8% vs 7.5%,领先1.3%),伊萨同比增速更快(8.5% vs 4.2%),过去两年伊萨的营收复合增速更高(2.8% vs -0.6%)
CNO金融集团是总部位于美国印第安纳州卡梅尔的金融服务控股公司,前身为康塞科公司。集团旗下保险子公司为美国超400万客户提供人寿保险、年金和补充健康保险产品,通过独立代理人、专属代理人,以及电视广告、直邮等直销触达用户。
ESAB(全称Elektriska Svetsnings-Aktiebolaget)是一家美国与瑞典合资的跨国工业企业,主营焊接、切割设备及配套耗材的研发、生产与销售,为全球制造业、基建等多领域客户提供专业可靠的工业解决方案,在全球工业市场拥有较高知名度。
CNO vs ESAB — 直观对比
营收规模更大
CNO
是对方的1.6倍
$727.8M
营收增速更快
ESAB
高出4.3%
4.2%
净利率更高
CNO
高出1.3%
7.5%
两年增速更快
ESAB
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.1B | $727.8M |
| 净利润 | $100.7M | $54.8M |
| 毛利率 | — | 37.0% |
| 营业利润率 | 15.2% | 14.6% |
| 净利率 | 8.8% | 7.5% |
| 营收同比 | 4.2% | 8.5% |
| 净利润同比 | -39.4% | 2.1% |
| 每股收益(稀释后) | $1.02 | $0.90 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CNO
ESAB
| Q4 25 | $1.1B | $727.8M | ||
| Q3 25 | $1.2B | $715.6M | ||
| Q2 25 | $1.2B | $678.1M | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | $670.8M | ||
| Q3 24 | $1.1B | $673.3M | ||
| Q2 24 | $1.1B | $707.1M | ||
| Q1 24 | $1.2B | $689.7M |
净利润
CNO
ESAB
| Q4 25 | $100.7M | $54.8M | ||
| Q3 25 | $23.1M | $66.9M | ||
| Q2 25 | $91.8M | $67.4M | ||
| Q1 25 | $13.7M | — | ||
| Q4 24 | $166.1M | $53.7M | ||
| Q3 24 | $9.3M | $68.2M | ||
| Q2 24 | $116.3M | $82.9M | ||
| Q1 24 | $112.3M | $60.0M |
毛利率
CNO
ESAB
| Q4 25 | — | 37.0% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 38.2% | ||
| Q1 24 | — | 37.0% |
营业利润率
CNO
ESAB
| Q4 25 | 15.2% | 14.6% | ||
| Q3 25 | 13.7% | 15.2% | ||
| Q2 25 | 9.8% | 16.2% | ||
| Q1 25 | 10.4% | — | ||
| Q4 24 | 15.8% | 16.6% | ||
| Q3 24 | 13.6% | 15.7% | ||
| Q2 24 | 13.9% | 16.9% | ||
| Q1 24 | 6.5% | 16.0% |
净利率
CNO
ESAB
| Q4 25 | 8.8% | 7.5% | ||
| Q3 25 | 1.9% | 9.3% | ||
| Q2 25 | 8.0% | 9.9% | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 15.1% | 8.0% | ||
| Q3 24 | 0.8% | 10.1% | ||
| Q2 24 | 10.9% | 11.7% | ||
| Q1 24 | 9.7% | 8.7% |
每股收益(稀释后)
CNO
ESAB
| Q4 25 | $1.02 | $0.90 | ||
| Q3 25 | $0.24 | $1.09 | ||
| Q2 25 | $0.91 | $1.10 | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $1.58 | $0.87 | ||
| Q3 24 | $0.09 | $1.11 | ||
| Q2 24 | $1.06 | $1.35 | ||
| Q1 24 | $1.01 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $218.2M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $2.6B | $2.1B |
| 总资产 | $38.8B | $4.9B |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势,按日历期对齐
现金及短期投资
CNO
ESAB
| Q4 25 | — | $218.2M | ||
| Q3 25 | — | $258.2M | ||
| Q2 25 | — | $291.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $249.4M | ||
| Q3 24 | — | $253.7M | ||
| Q2 24 | — | $228.5M | ||
| Q1 24 | — | $76.5M |
总债务
CNO
ESAB
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $992.8M |
股东权益
CNO
ESAB
| Q4 25 | $2.6B | $2.1B | ||
| Q3 25 | $2.6B | $2.1B | ||
| Q2 25 | $2.5B | $1.9B | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | $1.8B | ||
| Q3 24 | $2.7B | $1.8B | ||
| Q2 24 | $2.4B | $1.7B | ||
| Q1 24 | $2.4B | $1.6B |
总资产
CNO
ESAB
| Q4 25 | $38.8B | $4.9B | ||
| Q3 25 | $38.3B | $4.4B | ||
| Q2 25 | $37.3B | $4.2B | ||
| Q1 25 | $37.4B | — | ||
| Q4 24 | $37.9B | $4.0B | ||
| Q3 24 | $37.6B | $4.1B | ||
| Q2 24 | $36.3B | $4.0B | ||
| Q1 24 | $34.9B | $3.8B |
负债/权益比
CNO
ESAB
| Q4 25 | — | 0.63× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.59× | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | 0.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $195.7M | $81.5M |
| 自由现金流经营现金流 - 资本支出 | — | $70.3M |
| 自由现金流率自由现金流/营收 | — | 9.7% |
| 资本支出强度资本支出/营收 | — | 1.5% |
| 现金转化率经营现金流/净利润 | 1.94× | 1.49× |
| 过去12个月自由现金流最近4个季度 | — | $238.0M |
8季度趋势,按日历期对齐
经营现金流
CNO
ESAB
| Q4 25 | $195.7M | $81.5M | ||
| Q3 25 | $197.8M | $46.6M | ||
| Q2 25 | $145.5M | $35.4M | ||
| Q1 25 | $136.7M | — | ||
| Q4 24 | $191.0M | $126.9M | ||
| Q3 24 | $231.2M | $101.0M | ||
| Q2 24 | $110.9M | $83.0M | ||
| Q1 24 | $94.6M | $44.5M |
自由现金流
CNO
ESAB
| Q4 25 | — | $70.3M | ||
| Q3 25 | — | $37.4M | ||
| Q2 25 | — | $28.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $102.2M | ||
| Q3 24 | — | $90.4M | ||
| Q2 24 | — | $74.0M | ||
| Q1 24 | — | $37.1M |
自由现金流率
CNO
ESAB
| Q4 25 | — | 9.7% | ||
| Q3 25 | — | 5.2% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 13.4% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.4% |
资本支出强度
CNO
ESAB
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.1% |
现金转化率
CNO
ESAB
| Q4 25 | 1.94× | 1.49× | ||
| Q3 25 | 8.56× | 0.70× | ||
| Q2 25 | 1.58× | 0.53× | ||
| Q1 25 | 9.98× | — | ||
| Q4 24 | 1.15× | 2.36× | ||
| Q3 24 | 24.86× | 1.48× | ||
| Q2 24 | 0.95× | 1.00× | ||
| Q1 24 | 0.84× | 0.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNO
| Health Insurance Product Line | $496.4M | 43% |
| Life Insurance Segment | $268.8M | 24% |
| Other | $207.2M | 18% |
| Life And Annuity Insurance Product Line | $170.7M | 15% |
ESAB
| Consumable Products | $477.9M | 66% |
| Equipment Products | $249.9M | 34% |